openPR Logo
Press release

Insomnia Treatment Market is expected to be valued at around US$ 7.5 Bn by 2026 end

09-16-2022 11:57 AM CET | Health & Medicine

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
Insomnia Treatment Market 2022

Insomnia Treatment Market 2022

Insomnia Treatment Market 2022

The global market for insomnia treatment is expected to be valued at around US$ 7.5 Bn by 2026 end, witnessing steady expansion at 5.2% CAGR over 2018-2026.

Get Free Sample Copy Of Insomnia Treatment Market Report@ https://www.persistencemarketresearch.com/samples/23203

Technological innovations have revolutionized lifestyle, communication, business, travel, and healthcare. The healthcare technology industry is continually improving ways to treat neural-related medical conditions, coupled with a significant understanding of subsequent ramifications and consequences. On the other hand, the pharmaceutical landscape has also transitioned and opened itself to explore novel scientific approaches and innovative technologies within its core therapeutic areas.

New Pharmaceutical Innovations to Address Key Concerns for Sleep Medications

In the 32nd Annual Meeting of the Associated Professional Sleep Societies (SLEEP 2018), Eisai Co., Ltd. and Purdue Pharma L.P showed positive results from clinical trials of lemborexant, which is currently being studied for the potential treatment of multiple sleep disorders, especially insomnia. On examining lemborexant for sleep onset, sleep maintenance, and return to sleep latency, it showed favorable results in terms of postural instability and residual effect compared to placebo and zolpidem (Ambien).

Company Profiles

Sunovion Pharmaceuticals, Inc.
Natrol, LLC
GlaxoSmithKline Plc.
Sanofi SA
Pfizer Inc.
Boehringer Ingelheim International GmbH
Mallinckrodt
PERNIX Therapeutics
Takeda Pharmaceutical Company Limited
Merck & Co. Inc.

Starting With The New Decade On A Diligent Note In The Insomnia Treatment Market@ https://www.persistencemarketresearch.com/methodology/23203

A number of pharmaceutical companies are setting new breakthroughs in the sleep medications segment to cater to specific and unmet needs of insomnia patients. Such innovations are expected to help improve sleep through the night and also allow patients to function appropriately upon awakening, which has been a growing concern among older adults.

Smart Goggles, Wearable Tracking Devices, & Others Are Here to Stay

Multiple companies in the market are working on wearable devices for insomnia treatment, one of which is smart goggles; patients can now be wearing a pair of smart goggles to sleep off. Recent studies indicate that smart goggles use light and sound stimulations to trigger specific patterns in the brain that would eventually induce sleep. The light emitted by the goggles is of a certain wavelength that stimulates the hypothalamus gland within the brain. This leads to controlled secretion of melatonin, a hormone responsible for sleeping patterns.

Additionally, FDA-approved at-home and wearable tracking devices that monitor brain activity, leg movement, and breathing are becoming more common in the sleep research field. Another 'chemical-free' alternative is telehealth, which involves various ways to communicate with patients about their sleep health. Doctors and researchers are likely to focus on telehealth in near future.

In another research, scientists have discovered that certain cells in the brains of mice, expresses a gene called Lhx6, which promotes sleep. On activation, the Lhx6 gene induces sleep in mice; and awakened mice when deactivated. Moreover, a similar gene is also found in the human hypothalamus gland, and is anticipated to be potentially studied for sleep regulation. It is most likely that the compounds with similar properties as the Lhx6 gene will be incorporated with insomnia drugs, for enhance effectiveness.

Press The "Purchase Now" Button To Have Our Insomnia Treatment Market Report@ https://www.persistencemarketresearch.com/checkout/23203

New Drug Formulations to Remain a Key Strategy among Pharmaceutical Industries

A recent study by Persistence Market Research indicates that OTC drugs contribute a maximum revenue share in the global insomnia treatment market, due to increasing preference among insomnia patients. To make insomnia treatment drugs more effective and occupy a greater share of revenue in the global market, the development of new drug formulations is foreseen to remain a key strategy among leading pharmaceutical industries.

Besides expanding geriatric population, some of the most common concerns such as dependency, addiction, and residual symptoms will further compel the requirement of transformed insomnia treatment market over the projection period, 2018-2026.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insomnia Treatment Market is expected to be valued at around US$ 7.5 Bn by 2026 end here

News-ID: 2737564 • Views:

More Releases from Persistence Market Research

Hot Sauce Market Size US$7.6Bn by 2033 Driven by Rising Demand and Flavor Trends
Hot Sauce Market Size US$7.6Bn by 2033 Driven by Rising Demand and Flavor Trends
The global hot sauce market is witnessing strong momentum, driven by evolving consumer taste preferences, rising demand for bold and ethnic flavors, and the growing influence of global food culture. The market is likely to be valued at US$ 4.8 billion in 2026 and is projected to reach approximately US$ 7.6 billion by 2033, expanding at a healthy compound annual growth rate (CAGR) of 6.7% during the forecast period from
Plant-Based Pet Food Market to Hit US$1,063.8 Mn by 2033 Driven by Health Trends
Plant-Based Pet Food Market to Hit US$1,063.8 Mn by 2033 Driven by Health Trends
The global plant-based pet food market is emerging as a high-growth segment within the broader pet care and animal nutrition industry, driven by shifting consumer values, rising pet humanization trends, and increasing awareness of sustainability and ethical sourcing. The market is expected to be valued at US$ 567.2 million in 2026 and is projected to reach approximately US$ 1,063.8 million by 2033, expanding at a robust compound annual growth rate
Canned Tuna Market Value to Reach US$15.1 Bn by 2033 Driven by Convenience Demand
Canned Tuna Market Value to Reach US$15.1 Bn by 2033 Driven by Convenience Deman …
The global canned tuna market is poised for consistent growth over the forecast period, supported by rising consumer preference for convenient, affordable, and protein-rich food products. The market is expected to be valued at US$ 10.8 billion in 2026 and is projected to reach approximately US$ 15.1 billion by 2033, expanding at a compound annual growth rate (CAGR) of 4.9% between 2026 and 2033. This positive outlook reflects the canned
Egg White Substitute Market to Reach US$ 2.3 Bn by 2033 Driven by Vegan Demand
Egg White Substitute Market to Reach US$ 2.3 Bn by 2033 Driven by Vegan Demand
The global egg white substitute market is emerging as a high-growth segment within the broader food ingredients and alternative protein industry, driven by shifting consumer preferences, dietary restrictions, and advancements in food formulation technologies. The market is expected to be valued at US$ 1.5 billion in 2026 and is projected to reach approximately US$ 2.3 billion by 2033, reflecting a compound annual growth rate (CAGR) of 6.2% during the forecast

All 5 Releases


More Releases for Insomnia

Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Insomnia Market Size Growth Forecast: What to Expect by 2025? In the past few years, the size of the insomnia market has been on a constant rise. From $5 billion in 2024, the market is projected to expand to $5.24 billion in 2025, marking a compound annual growth rate
Insomnia Treatment Market: Embrace Restful Nights and Recharge Your Life with Br …
Insomnia, a common sleep disorder, affects millions of people worldwide. The condition not only disrupts the sleep-wake cycle but also affects overall health and quality of life. With the increasing prevalence of insomnia, the demand for effective treatment options has surged, driving the growth of the insomnia treatment market. Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on to
Insomnia - Drug Pipeline Landscape, 2023
Insomnia is a sleep disorder that is characterized by difficulty falling asleep or staying asleep. Insomnia can be caused by a variety of factors, including stress, anxiety, depression, medications, and medical conditions. Treatment for insomnia typically includes lifestyle changes, such as avoiding caffeine and establishing a regular sleep schedule, as well as cognitive behavioral therapy and, in some cases, medication. There are two types of insomnia primary and secondary. Primary insomnia
Insomnia - Drug Pipeline Landscape, 2022
Insomnia is a progressive, degenerative brain disorder that attacks the brain's nerve cells, or neurons, and causes them to waste away. This disease is characterized by a slow, gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ability severe enough to interfere with daily
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom. The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases